FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to an isoindoline sigma-2 receptor antagonist, pharmaceutical compositions thereof which contain said compound, a method of inhibiting the effect of beta-amyloid on neurons.
EFFECT: compound can be used for treating Alzheimer's disease.
19 cl, 4 tbl, 118 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS FOR TREATMENT OF NEURODEGERATIVE DISEASES | 2018 |
|
RU2792562C2 |
| BENZOTHIAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITION EXHIBITING PROPERTY TO BIND AMYLOID AND METHOD FOR DETECTING AMYLOID DEPOSITS IN MAMMAL | 2004 |
|
RU2440995C2 |
| QUINOLINE CARBOXAMIDE AND QUINOLINE CARBONITRILE DERIVATIVES AS mGluR2 NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS AND USE THEREOF | 2012 |
|
RU2610262C2 |
| COGNITIVE ABILITY REDUCTION INHIBITORS | 2010 |
|
RU2595720C2 |
| BICYCLIC HETEROCYCLIC SPIROCOMPOUNDS | 2010 |
|
RU2506266C2 |
| SUBSTITUTED INDOLE COMPOUNDS AS REDUCING REGULATORS OF ESTROGEN RECEPTORS | 2017 |
|
RU2722441C2 |
| COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS OF 2-AMINOPYRIMIDINE AND THEIR USE | 2020 |
|
RU2795914C1 |
| PYRIDOPYRIMIDINONE DERIVATIVES AND USE THEREOF AS AROMATIC HYDROCARBON RECEPTOR MODULATORS | 2021 |
|
RU2818954C1 |
| 1,2,4-TRIAZOLE DERIVATIVES AS SIGMA RECEPTOR INHBITORS | 2007 |
|
RU2451015C2 |
| NEW COMPOUNDS FOR TREATING AMYLOID OR AMYLOID-LIKE PROTEIN ASSOCIATED DISEASES | 2007 |
|
RU2469026C2 |
